• The one-year INFUSE study observed patient-reported migraine-related cognitive symptoms at baseline and changes over 6 months in those with at least one prior anti-calcitonin gene-related peptide (anti-CGRP) treatment failure VALBY, Denmark, April 19, 2026 /PRNewswire/ -- H. Lundbeck...
Hence then, the article about lundbeck presents new data at aan 2026 highlighting real world changes in migraine related cognitive symptoms after starting vyepti eptinezumab was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab) )
Also on site :
- The 1975 Barry Manilow Grammy-Winning Phenomenon That Was First Recorded by David Cassidy Before Becoming a Global Pop Anthem
- Inter Miami vs Columbus Crew Today: Date, Time and Where to Watch
- AI giants probing tens of thousands of security incidents – Axios